watch cbsn live by megan cerullo january 22 2020 2 15 pm moneywatch shares of novavax jumped 60 on tuesday after the drugmaker said it is working on a vaccine for the deadly coronavirus from china novavax touted its experience developing vaccine candidates for coronaviruses including vaccines to protect againstmiddle east respiratory syndrome mers andsevere acute respiratory syndrome sars in response to the emergence of the wuhan version of the coronavirus seen recently in china novavax has initiated development of a vaccine candidate the company said in a statement to cbs moneywatch novavax s stock gave nearly half of the gains on wednesday falling 27 to 7 19 coronavirusesare a large group of viruses that can cause illnesses as minor as a cold or as serious mers and sars according to theworld health organization they often cause pneumonia like symptoms the viruses are transmitted from animals to humans the virus that causes sars for example was transmitted to humans from a cat like animal called a civet but in some instances as appears to be the case with this new strain of coronavirus they can also be transmitted between humans novavax said it will use recombinant nanoparticle technology to develop a vaccine candidate to combat the virus which appears to have started in the city of wuhan in central china the wuhan version of the virus has infected almost 450 people and killed 17during china s peak travel season around the lunar new year festival sparking fear that the virus could depress tourism and economic activity other companies that develop vaccines including aethlon medical inovio pharmaceuticals and biocryst phramaceuticals also saw their shares rise as the coronavirus spread first published on january 22 2020 2 15 pm 2020 cbs interactive inc all rights reserved be in the know get the latest breaking news delivered straight to your inbox copyright 2020 cbs interactive inc all rights reserved quotes delayed at least 15 minutes market data provided by ice data services ice limitations powered and implemented by factset news provided by the associated press legal statement 